The heat-labile enterotoxins of Escherichia coli and cholera toxin of Vibrio cholerae are related in structure and function. Each of these oligomeric toxins is comprised of one A polypeptide and five B polypeptides. The B-subunits bind to gangliosides, which are followed by uptake into the intoxicated cell and activation of the host's adenylate cyclase by the A-subunits. There are two antigenically distinct groups of these toxins. Group I includes cholera toxin and type I heat-labile enterotoxin of E. coli; group II contains the type II heat-labile enterotoxins of E. coli. Three variants of type II toxins, designated LT-IIa, LT-IIb and LT-IIc have been described. Earlier studies revealed the crystalline structure of LT-IIb. Herein the carbohydrate binding specificity of LT-IIc B-subunits was investigated by glycosphingolipid binding studies on thin-layer chromatograms and in microtiter wells. Binding studies using a large variety of glycosphingolipids showed that LT-IIc binds with high affinity to gangliosides with a terminal Neu5Acα3Gal or Neu5Gcα3Gal, e.g. the gangliosides GM3, GD1a and Neu5Acα3-/Neu5Gcα3--neolactotetraosylceramide and Neu5Acα3-/Neu5Gcα3-neolactohexaosylceramide. The crystal structure of LT-IIc B-subunits alone and with bound LSTd/sialyl-lacto-N-neotetraose d pentasaccharide uncovered the molecular basis of the ganglioside recognition. These studies revealed common and unique functional structures of the type II family of heat-labile enterotoxins.

Department of Medical Biochemistry and Cell Biology Sahlgrenska Academy Institute of Biomedicine University of Gothenburg Sweden

Department of Microbiology and Immunology and The Witebsky Center for Microbial Pathogenesis and Immunology The Jacobs School of Medicine and Biomedical Sciences The University at Buffalo State University of New York Buffalo NY 14203 USA

Department of Microbiology and Immunology Sahlgrenska Academy Institute of Biomedicine University of Gothenburg Sweden

Department of Pharmaceutical Chemistry and Pharmaceutical Analysis Charles University Faculty of Pharmacy in Hradec Králové Akademika Heyrovského 1203 Hradec Králové 500 05 Czech Republic

University Grenoble Alpes CNRS CERMAV Grenoble 38000 France

See more in PubMed

Aguirre  J, Iglesias-Fernandez  J, Rovira  C, Davies  GJ, Wilson  KS, Cowtan  KD. 2015. Privateer: Software for the conformational validation of carbohydrate structures. Nat Struct Mol Biol. 22:833–834. PubMed

van den  Akker  F, Sarfaty  S, Twiddy  EM, Connell  TD, Holmes  RK, Hol  WG. 1996. Crystal structure of a new heat-labile enterotoxin LT-IIb. Structure. 4:665–678. PubMed

Ångström  J, Bäckström  M, Berntsson  A, Karlsson  N, Holmgren  J, Karlsson  K-A, Teneberg  S. 2000. Novel carbohydrate binding site recognizing blood group a and B determinants in a cholera toxin/heat-labile enterotoxin B-subunit hybrid. J Biol Chem. 275:3231–3238. PubMed

Barone  A, Benktander  J, Ångström  J, Aspegren  A, Björquist  P, Teneberg  S, Breimer  ME. 2013. Structural complexity of non-acid glycosphingolipids in human embryonic stem cells grown under feeder-free conditions. J Biol Chem. 288:10035–10050. PubMed PMC

Beddoe  T, Paton  AW, Le Nours  J, Rossjohn  J, Paton  JC. 2010. Structure, biological functions and applications of the AB5 toxins. Trends Biochem. 35:411–418. PubMed PMC

Berenson  CS, Nawar  HF, Kruzel  RL, Mandell  LM, Connell  TD. 2013. Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide. Glycobiology. 23:23–31. PubMed PMC

Cervin  J, Wands  AM, Casselbrant  A, Wu  H, Krishnamurthy  S, Cvjetkovic  A, Estelius  J, Coddens  A, Diswall  M, Ångström  J  et al.  2009. Recognition of blood group ABH type 1 determinants by the FedF adhesin of F18-fimbriated Escherichia coli. J Biol Chem.  284:9713–9726. PubMed PMC

Dedic  B, Sethi  A, Wallom  KL, Riise  R, Bäckström  M, Wallenius  V, Platt  FM, Lebens  M, Teneberg  S, Fändriks  L  et al.  2015. GM1 ganglioside-independent intoxication by cholera toxin. PLoS Pathog. 14:e1006862. PubMed PMC

Emsley  P, Lohkamp  B. 2010. Features and development of coot. Acta Crystallogr Sect D Biol Crystallogr. 66:486–501. PubMed PMC

Fan  E, Merritt  EA, Verlinde  CL, Hol  WG. 2000. AB(5) toxins: Structures and inhibitor design. Curr Opin Struct Biol. 10:680–686. PubMed

Fukuta  S, Magnani  JL, Twiddy  EM, Holmes  RK, Ginsburg  V. 1988. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect Immun. 56:1748–1753. PubMed PMC

Gascon  J. 2006. Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion. 73:102–108. PubMed

Hajishengallis  G, Connell  TD. 2013. Type II heat-labile enterotoxins: Structure, function and immunomodulatory properties. Vet Immunol Immunopathol. 152:68–77. PubMed PMC

Hauttecoeur  B, Sonnino  S, Ghidoni  R. 1985. Characterization of two molecular species GD3 ganglioside from bovine buttermilk. Biochim Biophys Acta. 833:303–307. PubMed

Holmgren  J. 1973. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect Immun. 8:851–859. PubMed PMC

Hu  JC, Mathias-Santos  C, Greene  CJ, King-Lyons  ND, Rodrigues  JF, Hajishengallis  G, Ferreira  LC, Connell  TD. 2014. Intradermal administration of the type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen. PLoS One. 9:e113978. PubMed PMC

Iwamori  M, Nagai  Y. 1981. Ganglioside composition of rabbit thymus. Biochim Biophys Acta. 665:205–213. PubMed

Jobling  MG, Holmes  RK. 2012. Type II heat-labile enterotoxins from 50 diverse Escherichia coli isolates belong almost exclusively to the LT-IIc family and may be prophage encoded. PLoS One. 7:29898. PubMed PMC

Kabsch  W. 2010. XDS. Acta Crystallogr. 66:125–132. PubMed PMC

Karlsson  KA. 1987. Preparation of total non-acid glycolipids for overlay analysis of receptors for bacteria and viruses and for other studies. Methods Enzymol. 138:212–220. PubMed

Kiguchi  K, Henning-Chubb  CB, Huberman  E. 1990. Glycosphingolipid patterns of peripheral blood lymphocytes, monocytes, and granulocytes are cell specific. J Biochem. 107:8–14. PubMed

Kotloff  KL, Platts-Mills  JA, Nasrin  D, Roose  A, Blackwelder  WC, Levine  MM. 2017. Global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques. Vaccine. 35:6783–6789. PubMed

Lamberti  LM, Bourgeois  AL, Fischer Walker  CL, Black  RE, Sack  D. 2014. Estimating diarrheal illness and deaths attributable to Shigellae and enterotoxigenic Escherichia coli among older children, adolescents, and adults in South Asia and Africa. PLoS Negl Trop Dis. 8:e2705. PubMed PMC

Langer  GG, Cohen  SX, Lamzin  VS, Perrakis  A. 2008. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat Protoc. 3:1171–1179. PubMed PMC

Lanne  B, Uggla  L, Stenhagen  G, Karlsson  KA. 1995. Enhanced binding of enterotoxigenic Escherichia coli K99 to amide derivatives of the receptor ganglioside NeuGc-GM3. Biochemistry. 34:1845–1850. PubMed

Legrand  P. 2017. XDSME: XDS made easier. GitHub Repos. 10.5281/zenodo.837885. DOI

Lowe  JB, Marth  JD. 1999. Structures common to different types of glycans. In: Varki  A, Cummings  R, Esko  J, Freeze  H, Hart  G, Marth  J, editors. Essentials in glycobiology. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory. p. 211–252.

Macher  BA, Klock  JC, Fukuda  MN, Fukuda  M. 1981. Isolation and structural characterization of human lymphocyte and neutrophil gangliosides. J Biol Chem. 256:1968–1974. PubMed

McCoy  AJ, Grosse-Kunstleve  RW, Adams  PD, Winn  MD, Storoni  LC, Read  RJ. 2007. Phaser crystallographic software. J Appl Crystallogr. 40:658–674. PubMed PMC

Murshudov  GN, Nicholls  RA. 2011. REFMAC 5 for the refinement of macromolecular crystal structures. Acta Crystallogr Sect D Biol Crystallogr. 67:355–367. PubMed PMC

Nawar  HF, Arce  S, Russell  MW, Connell  TD. 2005. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities. 2005. Infect Immun. 73:1330–1342. PubMed PMC

Nawar  HF, King-Lyons  ND, Hu  JC, Pasek  RC, Connell  TD. 2010. LT-IIc, a new member of the type II heat-labile enterotoxin family encoded by an Escherichia coli strain obtained from a nonmammalian host. Infect Immun. 78:4705–4713. PubMed PMC

Nawar  HF, Greene  CJ, Lee  CH, Mandall  LM, Hajishengallis  G, Connell  TD. 2011. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb. Vaccine. 29:721–727. PubMed PMC

Orlandi  PA, Crithley  DR, Fishman  PH. 1994. The heat-labile enterotoxin of Escherichia coli binds to polylactosaminoglycan-containing receptors in CaCo-2 human intestinal epithelial cells. Biochemistry. 33:12886–12895. PubMed

Robert  X, Gouet  P. 2014. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42:320–324. PubMed PMC

Strömberg  N, Nyholm  PG, Pascher  I, Normark  S. 1991. Saccharide orientation at the cell surface affects glycolipid receptor function. Proc Natl Acad Sci U S A. 88:9340–9344. PubMed PMC

Stroud  MR, Handa  K, MEK  MS, Ito  K, Levery  SB, Hakomori  S-I, Reinhold  BB, Reinhold  VN. 1996a. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 1. Separation of E-selectin binding from nonbinding gangliosides, and absence of sialosyl-Lex having tetraosyl to octaosyl core. Biochemistry. 35:758–769. PubMed

Stroud  MR, Handa  K, MEK  MS, Ito  K, Levery  SB, Hakomori  S-I, Reinhold  BB, Reinhold  VN. 1996b. Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin. Biochemistry. 35:770–778. PubMed

Svennerholm  L, Fredman  P. 1980. A procedure for the quantitative isolation of brain gangliosides. Biochim Biophys Acta. 617:97–109. PubMed

Teneberg  S, Hirst  TR, Ångström  J, Karlsson  K-A. 1994. Comparison of the glycolipid-binding specificities of cholera toxin and porcine Escherichia coli heat-labile enterotoxin: Identification of a receptor-active non-ganglioside glycolipid for the heat-labile toxin in infant rabbit small intestine. Glycoconj J. 11:533–540. PubMed

Waldi  D. 1962. Sprühreagentien für die dünnschicht-chromatographie. In: Stahl  E, editor. Dünnschicht-Chromatographie. Berlin (Germany): Springer-Verlag. p. 496–515.

Wands  AM, Fujita  A, McCombs  JE, Cervin  J, Dedic  B, Rodriguez  AC, Nischan  N, Bond  MR, Mettlen  M, Trudgian  DC  et al.  2015. Fucosylation and protein glycosylation create functional receptors for cholera toxin. elife. 4:e09545. PubMed PMC

Wands  AM, Cervin  J, Huang  H, Zhang  Y, Youn  G, Brautigam  CA, Matson Dzebo  M, Björklund  P, Wallenius  V, Bright  DK  et al.  2018. Fucosylated molecules competitively interfere with cholera toxin binding to host cells. ACS Infect Dis. 4:758–770. PubMed PMC

Williams  C, Headd  JJ, Moriarty  NW, Prisant  MG, Videau  LL, Deia  LN, Verma  V, Keedy  DA, Hintze  BJ, Chen  VB  et al.  2018. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27:293–315. PubMed PMC

Winn  MD, Ballard  CC, Cowtan  KD, Dodson  EJ, Emsley  P, Evans  PR, Keegan  RM, Krissinel  EB, Leslie  AGW, McCoy  A  et al.  2011. Overview of the CCP4 suite and current developments. Acta Crystallogr Sect D Biol Crystallogr. 67:235–242. PubMed PMC

Yohe  HC, Wallace  PK, Berenson  CS, Ye  S, Reinhold  BB, Reinhold  VN. 2001. The major gangliosides of human peripheral blood monocytes/macrophages: Absence of ganglio series structures. Glycobiology. 11:831–841. PubMed

Zalem  D, Ribeiro  JP, Varrot  A, Lebens  M, Imberty  A, Teneberg  S. 2016. Chemical and structural characterization of the novel sialic acid binding site of Escherichia coli heat-labile enterotoxin LT-IIb. Biochem J. 473:3923–3936. PubMed